Project Grant R21AR082655
Award Date
9/22/23
Completion Date
9/14/25
Dollars Obligated
$368K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Medical University of South Carolina (MUSC) a $365,420 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to study the role of the SLE causal variant NCF1.PR90H in promoting kidney damage. The 2-year project aims to investigate how this genetic variant impacts the function of the NADPH oxidase complex and contributes to systemic lupus erythematosus...
This federal Project Grant award of $220,224, awarded on July 4, 2024 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research by the University of Colorado to develop granular hydrogels for the controlled delivery of immunomodulatory and angiogenic extracellular vesicles to enhance bone tissue regeneration. The ultimate completion date for this project is...
The University of Colorado-Denver received a $449,000 exploratory and developmental research project grant (R21) from the National Institutes of Health (NIH) under the Trans-NIH Research Support (CFDA 93.310) program. The grant aims to plan a future national, interdisciplinary, collaborative research network to study the exposome in autoimmune diseases, specifically rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Key activities include conducting a landscape analysis of...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $300,000 in funding to the Beckman Research Institute of the City of Hope to conduct research into eradicating pathogenic plasma cells and their precursors in systemic lupus erythematosus (SLE). The key objectives are to determine the effect of knockdown of the long isoform of the prolactin...
This $375,100 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports a study to investigate the interplay between innate and adaptive immune responses against the cyclic G/AMP (cGAS) protein in systemic lupus erythematosus (SLE). The study aims to delineate how changes in the biophysical properties of cGAS, driven by its binding to different nucleic...
The University of Wisconsin-Madison was awarded a $329,304 Project Grant by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award will support the development of effective interventions to improve atherosclerotic cardiovascular disease (ASCVD) prevention in patients with lupus nephritis (LN), a leading cause of mortality in this population. Specifically, the grant will...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $702,511 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Chicago. The grant, titled "Using Artificial Intelligence to Bridge Human and Murine Studies of Lupus Nephritis Progression," will support research focused on understanding the progression of lupus nephritis, a severe manifestation of systemic lupus erythematosus. The project aims to leverage...
This $715,957 federal Project Grant award was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award was granted to Northwestern University to conduct research aimed at elucidating the molecular mechanisms by which interferon supports the production and expansion of T peripheral helper (TPH) cells, which are pathologically expanded in systemic lupus...
The federal Project Grant award for $997,821.00, granted by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research on the pathogenic role of neutrophil subpopulations in lupus nephritis. The primary awardee, Trustees of Dartmouth College, will collaborate with sub-awardees The Johns Hopkins University and Dartmouth-Hitchcock Clinic to conduct this research. Key products and services to be...
This Project Grant award of $788,508 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports comprehensive research to investigate the underlying mechanisms linking skin photosensitivity, autoimmunity, and lymphatic dysfunction in systemic lupus erythematosus (SLE). The research aims to delineate how Langerhans cells regulate the development and function of dermal...